Codiak Biosciences Overview

Codiak Biosciences Selling, General & Admin

Selling, General & Admin expenses for CDAK.

Quarterly SG&A Expenses

$6.56M

↓ 8.67% YoY

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$34.49M

↑ 29.51% YoY

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin